Clinical utility and patient considerations in the use of ofatumumab in chronic lymphocytic leukemia
Anna Maria Frustaci, Alessandra Tedeschi, Paola Picardi, Roberto Cairoli, Marco MontilloDepartment of Hematology, Niguarda Cancer Center, Niguarda Ca' Granda Hospital, Milan, Italy Abstract: Treatment aim for chronic lymphocytic leukemia has been radically changed over the past years from p...
Saved in:
Main Authors: | Frustaci AM, Tedeschi A, Picardi P, Cairoli R, Montillo M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/338dbfaba9a843b1932eb2d55b9de2cb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
by: Marco Montillo, et al.
Published: (2008) -
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
by: Cerquozzi S, et al.
Published: (2015) -
Chronic lymphocytic leukemia in general practice
by: Đurović Ljiljana P.
Published: (2021) -
Chronic lymphocytic leukemia/small lymphocytic lymphoma
by: E. A. Nikitin, et al.
Published: (2020) - Lymphoma & Chronic Lymphocytic Leukemias